Nutrigenomics: A controversy

Applied and Translational Genomics

Volumn 4, Issue , 2015, Pages 50-53

  Pavlidis, Cristiana ^a   Patrinos, George P ^a   Katsila, Theodora ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Nutrigenomics; Nutrition; Personalised medicine; Personalised nutrition; Science

Indexed keywords

EID: 84939971225     PISSN: 22120661     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atg.2015.02.003     Document Type: Article

References (38)

1. Affolter M., Raymond F., Kussmann M. Omics in nutrition and health research. Nutrigenomics and Proteomics in Health and Disease - Food Factors and Gene Interactions 2009, 11-29. Wiley Blackwell Edition, IA, USA. Y. Mine, K. Miyashita, F. Shahidi (Eds.).
2. Afman L., Muller M. Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet. Assoc. 2006, 106:569-576.
3. DiLella A.G., Kwok S.C., Ledley F.D., Marvit J., Woo S.L. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry 1986, 25:743-749.
4. Ferguson L. Nutrigenetics, nutrigenomics and inflammatory bowel diseases. Expert. Rev. Clin. Immunol. 2013, 9:717-726.
5. Ferretti G., Bacchetti T., Masciangelo S., Saturni L. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients 2012, 4:243-257.
6. Gentschew L., Bishop K.S., Han D.Y., Morgan A.R., Fraser A.G., Lam W.J., Karunasinghe N., Campbell B., Ferguson L.R. Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand. Nutrients 2012, 4:1247-1259.
7. Gibney M.J., Walsh M.C. The future direction of personalised nutrition: my diet, my phenotype, my genes' Proc. Nutr. Soc. 2013, 72(2):219-225.
8. Haritunians T., Jones M.R., McGovern D.P., Shih D.Q., Barrett R.J., Derkowski C., Dubinsky M.C., Dutridge D., Fleshner P.R., Ippoliti A., King L., Leshinsky-Silver E., Levine A., Melmed G.Y., Mengesha E., Vasilauskas E.A., Ziaee S., Rotter J.I., Targan S.R., Taylor K.D. Variants in ZNF365 isoform D are associated with Crohn's disease. Gut 2011, 60:1060-1067.
9. Heaney R.P. Dairy intake, dietary adequacy, and lactose intolerance. Adv Nutr. 2013, 4(2):151-156.
10. Hosseini-Esfahani F., Mirmiran P., Daneshpour M.S., Mehrabi Y., Hedayati M., Zarkesh M.M., Azizi F. Western dietary pattern interaction with APOC3 polymorphism in the risk of metabolic syndromes: Tehran Lipid and Glucose study. J. Nutrigenet. Nutrigenomics 2014, 7:105-117.
11. Kang R., Kim M., Chae J.S., Lee S.-H., Lee J.H. Consumption of whole grains and legumes modulates the genetic effect of the APOA5-1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Trials 2014, 15:100.
12. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Des-Vvergne B., Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103:1489-1498.
13. Kim M., Chae J.S., Kim M., Lee S.H., Lee J.H. Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5-1131T>C polymorphis. Nutr. J. 2014, 13:40.
14. Li S., Hu B., Wang Y., Wu D., Jin L., Wang X. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population. PLoS One 2014, 9(10):e110258.
15. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., Yang W., Pei L., Uldry M., Tontonoz P., Newgard C.B., Spiegelman B.M. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005, 120:261-273.
16. Luczynski W., Fendler W., Ramatowska A., Szypowska A., Szadkowska A., Mlynarski W., Chumiecki M., Jarosz-Chobot P., Chrzanowska J., Noczynska A., Brandt A., Mysliwiec M., Glowinska-Olszewska B., Bernatowicz P., Kowalczuk O., Bossowski A. Polymorphism of the FTO gene influences body weight in children with type 1 diabetes without severe obesity. Int. J. Endocrinol. 2014, Vol. 2014. (Article ID 630712, 5 pages.).
17. Ludvigsson J.F., Bai J.C., Biagi F., Card T.R., Ciacci C., Ciclitira P.J., Green P.H., Hadjivassiliou M., Holdoway A., van Heel D.A., Kaukinen K., Leffler D.A., Leonard J.N., Lundin K.E., McGough N., Davidson M., Murray J.A., Swift G.L., Walker M.M., Zingone F., Sanders D.S. BSG coeliac disease guidelines development group; British Society of Gastroenterology. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014, 63(8):1210-1228.
18. Mandard S., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 2004, 61:393-416.
19. Muller M., Kersten S. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 2003, 4:315-322.
20. Neeha V.S., Priyamvadah Kinth P. Nutrigenomics research: a review. J. Food Sci. Technol. 2013, 50(3):415-428.
21. Nuno N.B., Heuberger R. Nutrigenetic associations with cardiovascular disease. Rev. Cardiovasc. Med. 2014, 15:217-225.
22. Ortega-Azorín C., Sorlí J.V., Asensio E.M., Coltell O., Martínez-González M.Á., Salas-Salvadó J., Covas M.I., Arós F., Lapetra J., Serra-Majem L., Gómez-Gracia E., Fiol M., Sáez-Tormo G., Pintó X., Muñoz M.A., Ros E., Ordovás J.M., Estruch R., Corella D. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc. Diabetol. 2012, 11:137.
23. Palou A. From nutrigenomics to personalised nutrition. Gen. Nutr. 2007, 2:5-7.
24. Patrinos G.P., Prainsack B. Working towards personalization of medicine: genomics in 2014. Pers. Med. 2014, 11(7):611-613.
25. Patsouris D., Mandard S., Voshol P.J., Escher P., Tan N.S., Havekes L.M., Koenig W., Marz W., Tafuri S., Wahli W., Müller M., Kersten S. PPARalpha governs glycerol metabolism. J. Clin. Invest. 2004, 114:94-103.
26. Patsouris D., Müller M., Kersten S. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Curr. Opin. Investig. Drugs 2004, 5:1045-1050.
27. Pavlidis C., Karamitri A., Barakou A., Cooper D.N., Poulas K., Topouzis S., Patrinos G.P. Ascertainment and critical assessment of the views of the general public and healthcare professionals on nutrigenomics in Greece. Pers. Med. 2012, 9(2):201-210.
28. Peregrin T. The new frontier of nutrition science: nutrigenomics. J. Am. Diet. Assoc. 2001, 101(11):1306.
29. Ringstad J., Kildebo S., Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand. J. Gastroenterol. 1993, 28:605-608.
30. Sales N.M.R., Pelegrini P.B., Goerch M.C. Nutrigenomics: definitions and advances of this new science. J. Nutr. Metab. 2014, 202759.
31. Surtees R., Blau N. The neurochemistry of phenylketonuria. Eur. J. Pediatr. 2000, 159(Suppl. 2):S109-S113.
32. Swagerty D.L., Walling A.D., Klein R.M. Lactose intolerance. Am. Fam. Physician 2002, 65:1845-1850.
33. Swallow D.M. Genetics of lactase persistence and lactose intolerance. Annu. Rev. Genet. 2003, 37:197-219.
34. Sweeney A.L., Roberts R.M., Fletcher J.M. Dietary protein counting as an alternative way of maintaining metabolic control in phenylketonuria. JIMD Rep. 2012, 3:131-139.
35. Van Ommen B., Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr. Opin. Biotechnol. 2002, 13(5):517-521.
36. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E., Dionne S., Servant M.J., Bitton A., Seidman E.G., Mader S., Behr M.A., White J.H. Direct and indirect induction by 1,25-di-hydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 2010, 285(4):2227-2231.
37. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
38. Xu Y., Ling J., Yang M., Wang H., Zhang S., Zhang X., Zhu Y. Rs7206790 and rs11644943 in FTO gene are associated with risk of obesity in Chinese school-age population. PLoS One 2014, 9(9):e108050. (Sep 24).